| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2341 | 2019 |
| Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and … SM Grundy, GL Vega, ME McGovern, BR Tulloch, DM Kendall, ... Archives of internal medicine 162 (14), 1568-1576, 2002 | 846 | 2002 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 553 | 2019 |
| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 509 | 2019 |
| Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial DM Rubino, FL Greenway, U Khalid, PM O’Neil, J Rosenstock, R Sørrig, ... Jama 327 (2), 138-150, 2022 | 466 | 2022 |
| Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine ED Moreira Jr, N Kitchin, X Xu, SS Dychter, S Lockhart, A Gurtman, ... New England journal of medicine 386 (20), 1910-1921, 2022 | 268 | 2022 |
| Lesinurad combined with allopurinol: a randomized, double‐blind, placebo‐controlled study in gout patients with an inadequate response to standard‐of‐care allopurinol (a US … KG Saag, D Fitz‐Patrick, J Kopicko, M Fung, N Bhakta, S Adler, ... Arthritis & Rheumatology 69 (1), 203-212, 2017 | 203 | 2017 |
| An open-label, 6-month study of allopurinol safety in gout: the LASSO study MA Becker, D Fitz-Patrick, HK Choi, N Dalbeth, C Storgard, M Cravets, ... Seminars in Arthritis and Rheumatism 45 (2), 174-183, 2015 | 123 | 2015 |
| Bivalent omicron BA. 1–adapted BNT162b2 booster in adults older than 55 years P Winokur, J Gayed, D Fitz-Patrick, SJ Thomas, O Diya, S Lockhart, X Xu, ... New England Journal of Medicine 388 (3), 214-227, 2023 | 95 | 2023 |
| A sensitive radioimmunoassay for immunoreactive somatostatin in extracted plasma: measurement and characterization of portal and peripheral plasma in the rat YC PATEL, T WHEATLEY, D FITZ-PATRICK, G BROCK Endocrinology 107 (1), 306-313, 1980 | 85 | 1980 |
| Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial LJ Aronne, N Sattar, DB Horn, HE Bays, S Wharton, WY Lin, NN Ahmad, ... Jama 331 (1), 38-48, 2024 | 82 | 2024 |
| A randomized, double‐blind, active‐and placebo‐controlled efficacy and safety study of arhalofenate for reducing flare in patients with gout J Poiley, AS Steinberg, YJ Choi, CS Davis, RL Martin, CA McWherter, ... Arthritis & Rheumatology 68 (8), 2027-2034, 2016 | 81 | 2016 |
| Somatostatin: some aspects of its physiology and pathophysiology YC Patel, HH Zingg, D Fitz-Patrick, CB Srikant Gut hormones, 339-349, 1981 | 59 | 1981 |
| Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: a phase I study Y Su, E Romeu-Bonilla, A Anagnostou, D Fitz-Patrick, W Hearl, T Heiland Human Vaccines & Immunotherapeutics 13 (12), 2804-2813, 2017 | 50 | 2017 |
| Diabetes Multicenter Research Group Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the … SM Grundy, GL Vega, ME McGovern, BR Tulloch, DM Kendall, ... Arch Intern Med 162 (14), 1568-1576, 2002 | 49 | 2002 |
| Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan … D Fitz-Patrick, K Roberson, K Niwa, T Fujimura, K Mori, J Hall, X Yan, ... Modern rheumatology 29 (6), 1042-1052, 2019 | 41 | 2019 |
| Pituitary apoplexy: the importance of skull roentgenograms and computerized tomography in diagnosis D Fitz-Patrick, G Tolis, EE McGarry, S Taylor JAMA 244 (1), 59-61, 1980 | 34 | 1980 |
| Measurement, characterization, and source of somatostatin-like immunoreactivity in human amniotic fluid D Fitz-Patrick, YC Patel The Journal of Clinical Investigation 64 (3), 737-742, 1979 | 32 | 1979 |
| Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial KM Mullane, VA Morrison, LH Camacho, A Arvin, SA McNeil, J Durrand, ... The Lancet Infectious Diseases 19 (9), 1001-1012, 2019 | 31 | 2019 |
| Evidence for Somato statin Precursors in Human Stomach, Placenta, and Amniotic Fluid D FITZ-PATRICK, YC PATEI The Journal of Clinical Endocrinology & Metabolism 53 (2), 372-376, 1981 | 26 | 1981 |
